Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction

David E Kandzari; James E Tcheng; Cindy L Grines; David A Cox; Thomas Stuckey; John J Griffin; Mark Turco; Eulogio Garcia; John D Carroll; Martin Fahy; Alexandra J Lansky; Roxana Mehran; Gregg W Stone; CADILLAC Investigators

doi:10.1016/j.amjcard.2004.06.060

Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction

Am J Cardiol. 2004 Oct 15;94(8):1029-33. doi: 10.1016/j.amjcard.2004.06.060.

Authors

David E Kandzari¹, James E Tcheng, Cindy L Grines, David A Cox, Thomas Stuckey, John J Griffin, Mark Turco, Eulogio Garcia, John D Carroll, Martin Fahy, Alexandra J Lansky, Roxana Mehran, Gregg W Stone; CADILLAC Investigators

Affiliation

¹ Duke Clinical Research Institute, Durham, North Carolina 27715, USA. kandz002@mc.duke.edu

PMID: 15476618
DOI: 10.1016/j.amjcard.2004.06.060

Abstract

We examined the effect of aspirin use at the time of admission and discharge from a large-scale, prospective multicenter trial of patients who had been treated with primary percutaneous coronary intervention in acute myocardial infarction.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Angioplasty, Balloon, Coronary*
Aspirin / therapeutic use*
Female
Humans
Male
Middle Aged
Myocardial Infarction / mortality*
Myocardial Infarction / therapy*
Patient Admission
Patient Discharge
Survival Rate

Substances

Aspirin